FI120307B - Menetelmä antibioottisena lääkeyhdisteenä käytettävän kiteisen vapaan keftiofuurihapon valmistamiksi - Google Patents

Menetelmä antibioottisena lääkeyhdisteenä käytettävän kiteisen vapaan keftiofuurihapon valmistamiksi Download PDF

Info

Publication number
FI120307B
FI120307B FI954250A FI954250A FI120307B FI 120307 B FI120307 B FI 120307B FI 954250 A FI954250 A FI 954250A FI 954250 A FI954250 A FI 954250A FI 120307 B FI120307 B FI 120307B
Authority
FI
Finland
Prior art keywords
crystalline
acid
ceftiofuric
free
ceftiofur
Prior art date
Application number
FI954250A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954250L (fi
FI954250A0 (fi
Inventor
Michael J Dunn
Michael S Bergren
Kennetch Paul Shephard
Robert S Chao
Gregory E Hardee
Jeffrey L Havens
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FI954250L publication Critical patent/FI954250L/fi
Publication of FI954250A0 publication Critical patent/FI954250A0/fi
Application granted granted Critical
Publication of FI120307B publication Critical patent/FI120307B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI954250A 1993-03-12 1995-09-11 Menetelmä antibioottisena lääkeyhdisteenä käytettävän kiteisen vapaan keftiofuurihapon valmistamiksi FI120307B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3329193A 1993-03-12 1993-03-12
US3329193 1993-03-12
US9401862 1994-03-07
PCT/US1994/001862 WO1994020505A1 (en) 1993-03-12 1994-03-07 Crystalline ceftiofur free acid

Publications (3)

Publication Number Publication Date
FI954250L FI954250L (fi) 1995-09-11
FI954250A0 FI954250A0 (fi) 1995-09-11
FI120307B true FI120307B (fi) 2009-09-15

Family

ID=21869579

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954250A FI120307B (fi) 1993-03-12 1995-09-11 Menetelmä antibioottisena lääkeyhdisteenä käytettävän kiteisen vapaan keftiofuurihapon valmistamiksi

Country Status (31)

Country Link
US (1) US5721359A (cs)
EP (1) EP0690864B1 (cs)
JP (1) JP3852946B2 (cs)
KR (1) KR100296810B1 (cs)
CN (1) CN1055090C (cs)
AT (1) ATE202109T1 (cs)
AU (1) AU694419B2 (cs)
BR (1) BR1101034A (cs)
CA (1) CA2155322C (cs)
CZ (1) CZ289332B6 (cs)
DE (2) DE69427469T2 (cs)
DK (1) DK0690864T3 (cs)
ES (1) ES2157254T3 (cs)
FI (1) FI120307B (cs)
FR (1) FR05C0045I2 (cs)
GR (1) GR3036514T3 (cs)
HU (1) HU222244B1 (cs)
IL (1) IL108910A (cs)
LU (1) LU91206I2 (cs)
LV (1) LV12889B (cs)
NL (1) NL300208I2 (cs)
NO (2) NO313199B1 (cs)
NZ (1) NZ263002A (cs)
PL (1) PL184611B1 (cs)
PT (1) PT690864E (cs)
RU (1) RU2136685C1 (cs)
SI (1) SI0690864T1 (cs)
SK (1) SK283674B6 (cs)
TW (1) TW267170B (cs)
WO (1) WO1994020505A1 (cs)
ZA (1) ZA941586B (cs)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
DE60136367D1 (de) * 2000-09-12 2008-12-11 Pharmacia & Upjohn Co Llc Pharmazeutische zusammensetzung mit modifiziertem träger
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
BR0211061A (pt) * 2001-07-10 2004-07-20 Upjohn Co Cristais de tiazina oxazolidinonas e processos para isolar tais cristais
DK3168218T3 (en) * 2001-08-15 2019-01-14 Pharmacia & Upjohn Co Llc Crystalline comprising an L-malic acid salt of N- [2- (DIETHYLAMINO) ETHYL] -5 - [(5-FLUOR-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDE) METHYL] -2,4 -DIMETHYL-1H-PYRROL-3-CARBOXAMIDE FOR USE AS A MEDICINE
CN1635856A (zh) † 2002-03-21 2005-07-06 法玛西雅厄普约翰有限责任公司 向动物耳施用可注射抗生物的方法
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US20040115822A1 (en) * 2002-09-12 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US20040115837A1 (en) * 2002-11-27 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
PT1606293E (pt) * 2003-03-27 2009-10-14 Basilea Pharmaceutica Ag Cefalosporina sob forma cristalina
PT2156824E (pt) 2004-03-25 2013-01-04 Astellas Pharma Inc Uma composição de solifenacina, ou um seu sal, utilizada sob a forma de formulações sólidas
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
US8470809B2 (en) * 2005-10-12 2013-06-25 Orchid Chemicals & Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
AU2006300882B2 (en) * 2005-10-12 2012-05-03 Orchid Chemicals And Pharmaceuticals Limited Crystalline sodium salt of cephalosporin antibiotic
AU2008290329B2 (en) 2007-08-22 2011-12-22 Astrazeneca Ab Cyclopropyl amide derivatives
US9943614B2 (en) 2008-06-17 2018-04-17 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
EP2324034A4 (en) * 2008-08-22 2012-05-16 Orchid Chemicals & Pharm Ltd CRYSTALLINE SODIUM SALT OF CEPHALOSPORIN ANTIBIOTIC
JP5685193B2 (ja) * 2008-11-19 2015-03-18 メリアル リミテッド セフチオフルおよびケトプロフェンとまたはセフチオフルとベンジルアルコールとを含む製剤
MY161598A (en) * 2009-01-30 2017-04-28 Glaxosmithkline Llc Crystalline n-{ (1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl} -5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
CA2788444A1 (en) * 2010-02-18 2011-08-25 Astrazeneca Ab New crystalline form of a cyclopropyl benzamide derivative
AU2011218490B9 (en) * 2010-02-18 2014-12-18 Astrazeneca Ab Solid forms comprising a cyclopropyl amide derivative
AU2012251438A1 (en) 2011-05-02 2013-11-14 Pfizer Inc. Novel cephalosporins useful as antibacterial agents
CA2842460C (en) 2011-07-20 2019-08-20 Brigham Young University Hydrophobic ceragenin compounds and devices incorporating same
CA2852989C (en) 2011-09-13 2021-06-29 Brigham Young University Compositions for treating bone diseases and broken bones
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
JP6038155B2 (ja) 2011-09-13 2016-12-07 ブリガム・ヤング・ユニバーシティＢｒｉｇｈａｍ Ｙｏｕｎｇ Ｕｎｉｖｅｒｓｉｔｙ 組織創傷を治癒させる製品
BR112014015144B1 (pt) 2011-12-21 2018-03-27 Brigham Young University Composição aquosa para cuidado oral, uso de um composto esteroide catiônico e método não- terapêutico de redução de compostos voláteis de enxofre
CN102584855B (zh) * 2012-02-16 2014-06-25 青岛科技大学 一种改进的头孢噻呋的制备方法
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
EP2846634A2 (en) 2012-05-02 2015-03-18 Brigham Young University Ceragenin particulate materials and methods for making same
AU2013331136B2 (en) 2012-10-17 2016-05-12 Brigham Young University Treatment and prevention of mastitis
WO2014087972A1 (ja) * 2012-12-03 2014-06-12 株式会社カネカ 還元型補酵素ｑ10誘導体およびその製造方法
CN105451742B (zh) 2013-01-07 2021-04-06 布莱阿姆青年大学 减少细胞增殖和治疗某些疾病的方法
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
CN110420211A (zh) 2013-03-15 2019-11-08 布莱阿姆青年大学 治疗炎症、自身免疫性疾病和疼痛的方法
RU2546675C2 (ru) * 2013-04-11 2015-04-10 Федеральное казённое предприятие "Государственный научно-исследовательский институт химических продуктов" (ФКП "ГосНИИХП") Способ определения степени кристалличности составов на основе дифениламина
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
CN105517992B (zh) * 2013-09-05 2018-06-22 田边三菱制药株式会社 新型结晶性芳烷基胺化合物及其制造方法
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (en) 2014-02-27 2021-03-16 Brigham Young University Cationic steroidal antimicrobial compounds
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
CA2965169C (en) 2014-10-21 2021-11-16 Ariad Pharmaceuticals, Inc. Crystalline forms of 5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrimidine-2,4-diamine
US10370403B2 (en) 2015-04-22 2019-08-06 Brigham Young University Methods for the synthesis of ceragenins
WO2016172553A1 (en) 2015-04-22 2016-10-27 Savage Paul B Methods for the synthesis of ceragenins
KR101753842B1 (ko) * 2015-05-12 2017-07-04 한국화학연구원 불화퀴놀론계 항생제를 담지한 서방형 제제 및 이의 제조방법
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
CN106543203B (zh) * 2015-09-18 2019-07-02 瑞普（天津）生物药业有限公司 一种长效头孢噻呋自由酸晶体的制备方法
WO2017125557A1 (en) * 2016-01-22 2017-07-27 Sandoz Ag Crystalline eravacycline bis-hydrochloride
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
KR101898282B1 (ko) * 2016-05-24 2018-09-13 주식회사 고려비엔피 항생제의 서방형 수의학적 조성물 및 이의 제조방법
MA45588A (fr) * 2016-07-07 2019-05-15 Ironwood Pharmaceuticals Inc Formes solides d'un stimulateur de la gcs
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
UA119735C2 (uk) 2018-12-20 2019-07-25 Анатолій Семенович Редер Фармацевтична сполука, спосіб її отримання та застосування як лікарського засобу
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth
TW202233625A (zh) * 2020-11-18 2022-09-01 美商傳達治療有限公司 Ｆｇｆｒ抑制劑及其製造及使用方法
CN117229296A (zh) * 2023-09-14 2023-12-15 广东温氏大华农生物科技有限公司 一种头孢噻呋酸晶体及其制备方法与应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1207933B (de) * 1962-12-26 1965-12-30 American Home Prod Verfahren zur Herstellung von kristallwasser-freiem D-alpha-Aminobenzylpenicillin
US3489750A (en) * 1967-09-05 1970-01-13 Bristol Myers Co 7-amino-cephalosporanic and decephalosporanic acid derivatives
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4400503A (en) * 1981-10-30 1983-08-23 Eli Lilly And Company Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
KR890002631B1 (ko) * 1984-10-04 1989-07-21 몬산토 캄파니 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물
IT1181672B (it) * 1984-10-25 1987-09-30 Upjohn Co Cefalosporina alogenidrato cristallino
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
FR2585705B1 (fr) * 1985-08-05 1989-01-13 Bristol Myers Co Sels de cephalosporine et compositions injectables
ATE138664T1 (de) * 1985-08-12 1996-06-15 Upjohn Co Umwandlung des cephalosporin-hydrohalid-salzes zu einem alkalimetallsalz
GB8608962D0 (en) * 1986-04-12 1986-05-14 Beecham Group Plc Beta-lactam antibiotics
IT1214587B (it) * 1986-12-23 1990-01-18 Giovanni Bonfanti Metodo per la produzione diprodotti cristallini puri.
JP2533151B2 (ja) * 1987-02-02 1996-09-11 イーライ・リリー・アンド・カンパニー 抗生物質製造の改良法
WO1989000852A1 (en) * 1987-07-29 1989-02-09 The Upjohn Company Controlled release of antibiotic salts from an implant
US5134137A (en) * 1987-11-10 1992-07-28 The Upjohn Company Cephalosporin antibiotics
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes

Also Published As

Publication number Publication date
CZ9502290A3 (cs) 2001-08-15
JP3852946B2 (ja) 2006-12-06
CN1119016A (zh) 1996-03-20
PL184611B1 (pl) 2002-11-29
NL300208I1 (nl) 2006-02-01
NO2005025I2 (no) 2010-11-22
DE122005000055I1 (de) 2006-02-23
LV12889B (lv) 2002-12-20
SI0690864T1 (en) 2001-10-31
EP0690864A1 (en) 1996-01-10
NL300208I2 (nl) 2006-05-01
NO2005025I1 (no) 2005-12-05
SK283674B6 (sk) 2003-11-04
IL108910A (en) 1999-10-28
GR3036514T3 (en) 2001-12-31
HU9501960D0 (en) 1995-09-28
US5721359A (en) 1998-02-24
DE69427469T2 (de) 2001-10-31
KR100296810B1 (ko) 2001-10-24
HU222244B1 (hu) 2003-05-28
CA2155322C (en) 2000-02-29
SK111495A3 (en) 1995-12-06
RU2136685C1 (ru) 1999-09-10
CZ289332B6 (cs) 2002-01-16
CN1055090C (zh) 2000-08-02
DK0690864T3 (da) 2001-09-17
HUT73781A (en) 1996-09-30
ES2157254T3 (es) 2001-08-16
IL108910A0 (en) 1994-06-24
NO953564D0 (no) 1995-09-11
NO953564L (no) 1995-11-07
BR1101034A (pt) 2002-04-30
AU6351094A (en) 1994-09-26
NO313199B1 (no) 2002-08-26
LU91206I2 (fr) 2006-05-30
NZ263002A (en) 1996-12-20
EP0690864B1 (en) 2001-06-13
FR05C0045I1 (cs) 2006-01-06
FR05C0045I2 (cs) 2007-08-03
CA2155322A1 (en) 1994-09-15
ZA941586B (en) 1995-09-07
PT690864E (pt) 2001-11-30
PL310556A1 (en) 1995-12-27
JPH08507519A (ja) 1996-08-13
AU694419B2 (en) 1998-07-23
DE69427469D1 (en) 2001-07-19
WO1994020505A1 (en) 1994-09-15
ATE202109T1 (de) 2001-06-15
FI954250L (fi) 1995-09-11
DE122005000055I2 (de) 2008-06-05
FI954250A0 (fi) 1995-09-11
TW267170B (cs) 1996-01-01

Similar Documents

Publication Publication Date Title
FI120307B (fi) Menetelmä antibioottisena lääkeyhdisteenä käytettävän kiteisen vapaan keftiofuurihapon valmistamiksi
US6486149B2 (en) Composition comprising a crystallographically stable, amorphous cephalosporin and processes for the preparation thereof
CH652129A5 (de) Neue cephalosporine, verfahren zur herstellung derselben.
CS207647B2 (en) Method of making the crystallic hydrated form of the sodium salt of the oximin derivative of the 7-aminothiazolylacetamidocephalosporan acid
FI66388C (fi) Foerfarande foer framstaellning av 7-(d-alfa-amino-alfa-(p-hydroxifenyl)acetamido)-3-(1,2,3-triazol-5-yltiometyl)-3-cefem-4-karboxylsyra-1,2-propylenglykolat
AU2002253642B2 (en) Amorphous cefditoren pivoxil composition and process for producing the same
JP2703964B2 (ja) セファロスポリン抗生物質類
CS195746B2 (en) Process for preparing crystalline methanolate of natrium salt of cephamandole
EP1671635B1 (en) Noncrystalline antibacterial composition containing cefditoren pivoxil
JPH01199977A (ja) セファロスポリン誘導体の結晶、その製造法およびそれらを有効成分とする医薬組成物
CN104402908A (zh) 头孢西丁钠化合物实体及其组合物和用途
EP0811009A1 (en) Stable hydrates of a cephalosporin chloride salt
EP0321562B1 (en) Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
US4061862A (en) Derivatives of 7-(cyclized)phenylglycyl-3-triazolo-thio methyl cephalosporin
JPS6052716B2 (ja) 抗生物質
CS195747B2 (cs) Způsob výroby krystalické bezvodé sodné soli cefamandolu
JPS6052717B2 (ja) 抗菌剤

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: PHARMACIA & UPJOHN COMPANY

FG Patent granted

Ref document number: 120307

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: ZOETIS P&U LLC

MA Patent expired